Rider Michael J 4
Research Summary
AI-generated summary
ResMed (RMD) Global GC Michael J. Rider Sells 50 Shares
What Happened
Michael J. Rider, Global General Counsel of ResMed Inc. (RMD), sold 50 shares in an open-market/private sale on February 4, 2026 at $260.00 per share, for proceeds of $13,000. This was a sale (not a purchase or option exercise), which is often a routine disposition by insiders.
Key Details
- Transaction date and price: 2026-02-04 — 50 shares at $260.00 per share.
- Total value: $13,000.
- Transaction type: Reported as an open market or private sale (code S).
- Footnote: Transaction was conducted under a Rule 10b5-1 trading plan adopted February 28, 2025.
- Shares owned after transaction: Not disclosed in this filing.
- Filing date: Form filed 2026-02-06; filing appears timely based on the reported transaction date.
Context
Sales executed under pre-established 10b5-1 plans are scheduled trades and are generally given less interpretive weight regarding the insider’s view of company prospects. The trade size here is modest (~$13k), so it’s a small, routine insider sale rather than a large directional move.